Educational information, not medical advice — ask your doctor or midwife.
Kakkontokasenkyushin'i is one of the most familiar prescriptions in Japanese Kampo medicine. It is built on Kakkonto — the seven-herb formula from the second-century Chinese classic Shanghan Lun that Japanese households still reach for at the first sign of a cold — with two extra herbs added: senkyu (Cnidium rhizome) and shin'i (magnolia flower bud). Both additions are traditionally described as opening the nasal passages and moving blood and qi in the head, which is why the modified formula is aimed at the nose and sinuses rather than at fever and chills.
In Japan it is a routine, insurance-covered prescription, dispensed as a granulated extract and used by ear-nose-throat doctors and general practitioners for chronic sinusitis, stubborn nasal blockage, thick discharge that will not clear after a cold, and some cases of allergic rhinitis. It is typically chosen for a patient who is reasonably robust rather than frail, who has a blocked rather than a streaming nose, and who often has tight, aching neck and shoulders alongside the sinus symptoms.
The honest position on evidence is that its place in practice rests mainly on a long clinical record and prescribing habit. Small Japanese trials in rhinosinusitis and rhinitis exist and generally report improved nasal symptoms, but they are few, mostly modest in size, and often not blinded — enough to be encouraging, not enough to be conclusive.
Traditionally the formula is said to release the exterior, relax the neck and upper back, and open the nasal orifices. In modern terms, the plausible contributions are: ephedra alkaloids (ephedrine, pseudoephedrine) acting as decongestants that shrink swollen nasal lining; anti-inflammatory effects from puerarin in kakkon, glycyrrhizin in kanzo, and paeoniflorin in shakuyaku; and effects on nasal secretion and mucosal blood flow attributed to shin'i and senkyu. Laboratory work suggests the combination dampens inflammatory signalling in nasal tissue, but the link from those experiments to what a patient feels has not been demonstrated in a rigorous human trial.
The overwhelmingly common form is a freeze-dried granulated extract in individual sachets, standardised by the manufacturer and dosed by weight of extract rather than raw herb — this is the form used in essentially all the Japanese clinical work. Tablets and capsules of the same extract are sold over the counter in Japan and exported. A traditional decoction made by simmering the sliced raw herbs is stronger and more variable, and is now uncommon outside specialist practice. Concentrations differ between brands, so follow the labelled dose rather than converting between products.
Kakkonto appears in the Shanghan Lun, attributed to Zhang Zhongjing around 200 CE, as a treatment for the early stage of a cold with stiff neck and no sweating. Japanese physicians of the Edo period, working in the Kampo tradition of adapting Chinese classics to bedside patterns, produced modified versions for specific complaints; the senkyu-and-shin'i variant became the standard choice for nasal and sinus disease. When Japan formalised Kampo extract preparations into the national health insurance system in the 1970s and 1980s, this formula was included among the first and most widely dispensed, and it remains a staple of Japanese ENT prescribing today.
Evidence grades and traditional-use labels are explained in our methodology. Nothing here is medical advice.
What it is typically used for, usual dose, cautions, and the study behind it where real trial data exists.
One email with the summary. We'll also send a short weekly evidence update — unsubscribe any time.